Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy

被引：0
|
作者：
Wang, Lei
Xiao, Yufeng
Master, Rohan P.
Jin, Zeng
Patel, Urvi M.
Luo, Yuewan
Zhou, Daohong
Zheng, Guangrong
Zhang, Weizhou
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2326
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326
引用
收藏
页数：2
相关论文
共 50 条
  • [41] IMMUNOMODULATION BY TARGETING PDL-1 IN COLON CANCER USING NUCLEAR RECEPTOR 4A1 (NR4A1) ANTAGONISTS
    Abdelrahim, Maen
    Mohankumar, Kumaravel
    Karki, Keshav
    Safe, Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A754 - A755
  • [42] Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
    Yonghan He
    Xuan Zhang
    Jianhui Chang
    Ha-Neui Kim
    Peiyi Zhang
    Yingying Wang
    Sajid Khan
    Xingui Liu
    Xin Zhang
    Dongwen Lv
    Lin Song
    Wen Li
    Dinesh Thummuri
    Yaxia Yuan
    Janet S. Wiegand
    Yuma T. Ortiz
    Vivekananda Budamagunta
    Jennifer H. Elisseeff
    Judith Campisi
    Maria Almeida
    Guangrong Zheng
    Daohong Zhou
    Nature Communications, 11
  • [43] Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
    Mohite, Popat
    Yadav, Vaishnavi
    Pandhare, Ramdas
    Maitra, Swastika
    Saleh, Fayez M.
    Saleem, Rasha Mohammed
    Al-malky, Hamdan S.
    Kumarasamy, Vinoth
    Subramaniyan, Vetriselvan
    Abdel-Daim, Mohamed M.
    Uti, Daniel E.
    ACS OMEGA, 2024, 9 (07): : 7277 - 7295
  • [44] Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy
    Jayaseelan, Vijayashree Priyadharsini
    Loganathan, Kavitha
    Pandi, Anitha
    Ramasubramanian, Abilasha
    Kannan, Balachander
    Arumugam, Paramasivam
    EPIGENOMICS, 2023, 15 (23) : 1233 - 1236
  • [45] Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
    Tseng, Yu-Ling
    Lu, Po-Chao
    Lee, Chi-Chang
    He, Ruei-Yu
    Huang, Yung-An
    Tseng, Yin-Chen
    Cheng, Ting-Jen Rachel
    Huang, Joseph Jen-Tse
    Fang, Jim-Min
    JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
  • [46] Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
    Yu-Ling Tseng
    Po-Chao Lu
    Chi-Chang Lee
    Ruei-Yu He
    Yung-An Huang
    Yin-Chen Tseng
    Ting-Jen Rachel Cheng
    Joseph Jen-Tse Huang
    Jim-Min Fang
    Journal of Biomedical Science, 30
  • [47] Nanoliposomal Bcl-xL proteolysis-targeting chimera enhances anti-cancer effects on cervical and breast cancer without on-target toxicities
    Zhang, Jiaming
    Zhang, Baofang
    Pu, Congli
    Cui, Jiarui
    Huang, Kexin
    Wang, Hongbo
    Zhao, Yingchao
    ADVANCED COMPOSITES AND HYBRID MATERIALS, 2023, 6 (02)
  • [48] Nanoliposomal Bcl-xL proteolysis-targeting chimera enhances anti-cancer effects on cervical and breast cancer without on-target toxicities
    Jiaming Zhang
    Baofang Zhang
    Congli Pu
    Jiarui Cui
    Kexin Huang
    Hongbo Wang
    Yingchao Zhao
    Advanced Composites and Hybrid Materials, 2023, 6
  • [49] The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists
    Hedrick, Erik
    Lee, Syng-ook
    Safe, Stephen
    MOLECULAR CARCINOGENESIS, 2017, 56 (09) : 2066 - 2075
  • [50] The Effect of proteolysis-targeting chimera (PROTAC) of EZH2 on high grade Serous ovarian Carcinoma.
    Hachijo, Ryuta
    Sone, Kenbun
    Jonouchi, Yuri
    Ishizaka, Aya
    Suzuki, Eri
    Tsuchimochi, Saki
    Tanimoto, Saki
    Toyohara, Yusuke
    Honjo, Harunori
    Fukuda, Tomohiko
    Miyamoto, Yuichiro
    Mori, Mayuyo
    Oda, Katsutoshi
    Hirota, Yasushi
    Osuga, Yutaka
    CANCER SCIENCE, 2025, 116 : 1685 - 1685
12345